You have read all your free articles, to continue reading subscribe to read the rest of this content.
Xbrane Biopharma's partner Pooyesh Darou has been granted market authorization for sales and marketing of Spherotide 1 month formulation in Iran under the local brand name Microrelin. “This is a major milestone for Xbrane as it is the first Market Authorization granted for Spherotide to a localAlready a subscriber Login…
Sectra has established a new direct sales operation entitled Sectra Canada Inc. The company hopes that an increased local presence will enable Sectra to focus and tailor its offerings to the specific workflow requirements of the Canadian market. The office will be located in Toronto and is expectAlready a subscriber…
InDex Pharmaceuticals Holding is planning for self-commercialization of the drug candidate cobitolimod in the US with strategic collaborations in other regions. Launch is expected in 2027, with the potential for annual sales to reach more than USD 1 billion, in moderate to severe left-sided ulcerAlready a subscriber Login You have…
Calquence, a next generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been conditionally approved in China for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. This is the first approved indication for Calquence in ChiAlready a subscriber Login You have…
